Clinical Trial
[Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias]
[Article in
French]
- PMID: 1094413
Item in Clipboard
Clinical Trial
[Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias]
[Article in
French]
Nouv Presse Med.
.
Abstract
In addition to uricosuric agents and purine synthesis inhibitors, Urate Oxydase may be used in the treatment of hyperuricaemia. This substance breaks down uric acid to allantoin which is soluble and easily excreted. Use of the medication in 14 cases of major gout with tophi and 9 cases of hyperuricaemia secondary to renal insufficiency showed the good tolerance of the substance and it's clinical and biological effectiveness.
Similar articles
-
Enzymatic uricolysis: a study of the effect of a fungal urate-oxydase.Rev Eur Etud Clin Biol. 1972 Nov;17(9):890-5. Rev Eur Etud Clin Biol. 1972. PMID: 4631795 No abstract available.
-
[New trend in gout treatment. Clinical and biological study of urate oxidase].Lille Med. 1971 Nov;16(9):1332-45. Lille Med. 1971. PMID: 4945000 Clinical Trial. French. No abstract available.
-
[Clinical experience with a new uricolytic agent].Recenti Prog Med. 1986 Mar;77(3):147-8. Recenti Prog Med. 1986. PMID: 3715181 Italian. No abstract available.
-
[Gout].Schweiz Med Wochenschr. 1970 Feb 21;100(8):383-6. Schweiz Med Wochenschr. 1970. PMID: 4946973 Review. French. No abstract available.
-
Pegloticase (krystexxa) for treatment of refractory gout.Med Lett Drugs Ther. 2011 Feb 7;53(1357):9-10. Med Lett Drugs Ther. 2011. PMID: 21304442 Review. No abstract available.
Cited by
-
Antigenic independence of some microbial urate oxidases.Infect Immun. 1975 Dec;12(6):1237-41. doi: 10.1128/iai.12.6.1237-1241.1975. Infect Immun. 1975. PMID: 812823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources